<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200326046866N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-10-06</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>The effectiveness of Exercise therapy and complementary shock wave therapy on improving the situation in patients with frozen shoulder</public_title>
      <acronym>ESWT</acronym>
      <scientific_title>The effectiveness of Exercise therapy with and without complementary shock wave therapy on the pain and range of motion in patients with frozen shoulder</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-10-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/46822</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Other design features: In the control group, patients will receive exercise therapy for up to six weeks. but In the intervention group, the treatment protocol is performed in such a way that patients do exercise therapy for up to three weeks. From week three onward, they will be treated with exercise therapy (on days when they do not exercise therapy) for up to six weeks with a shock wave, Randomization description: Patients are randomly divided into two groups A and B using computer randomization (using Excel program). This arrangement is written in envelopes and Put in a box and When selecting patients, they are treated according to this sequence, Blinding description: Patients ,investigator and data analyst will be blind to the study
But consequence assessor and data supervisor committee will be aware of study.
Patients: shock wave probe are gonna applied in both groups 
But in the control group it will be in off mode. 
Investigator and data analyst: they are going to analyze the data without any information about patients groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Frozen Shoulder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: It will use a shock wave therapy device with the specifications of ROSETTA the CR technology made in South Korea. The treatment protocol will be such that the person is sitting in the shock wave group with the shoulder away from the center with the elbow curve at an angle of 45 degrees and the arm at rest. Shock waves will shine on the sensitive points near the Rotator cuff joint in the small protrusion of the bone, below the tip of the shoulder. Shock wave will be performed once every five days for 4 consecutive weeks and in each session 3000 shocks with a frequency of 10 Hz. Intervention 2: Control group: An exercise therapy program is offered for six weeks and three sessions each week (between 45 and 60 minutes) that From week three onward, they receive the same treatment as the experimental group for up to six weeks, While the shock wave device is off and is placed on the patient's shoulder at the same time.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
In case of journal editor requesting

When:
After submission until article publication

To whom:
Editors and reviewers

Conditions:
For the next studies

Where to obtain:
Corresponding author

How to obtain:
Writing a Email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Alireza Rouhani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>5Floor, Hakim Building, New Pastour Ave</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>515 774 4897</zip>
        <telephone>+98 41 3557 9744</telephone>
        <email>rouhani.m.d@gmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Alireza Rouhani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>5Floor, Hakim Building, New Pastour Ave</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>515 774 4897</zip>
        <telephone>+98 41 3557 9744</telephone>
        <email>rouhani.m.d@gmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>with symptoms and signs of frozen shoulder disease for at least 3 months
with Frozen shoulder disease according to orthopedic specialist diagnosis
Significant loss of shoulder joint mobility in active and passive motion
Nocturnal pain and daily activity in the shoulder joint
Age range 40 to 60 years</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>history of illness and underlying injuries affecting the frozen shoulder such as fracture, dislocation, joint instability
history of neuromuscular skeletal disease
Rotator Cuff Muscle Tear
History of previous surgeries
History of taking any medication or painkiller and Use of therapeutic measures for frozen shoulder problems</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M75.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Adhesive capsulitis of shoulder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: It will use a shock wave therapy device with the specifications of ROSETTA the CR technology made in South Korea. The treatment protocol will be such that the person is sitting in the shock wave group with the shoulder away from the center with the elbow curve at an angle of 45 degrees and the arm at rest. Shock waves will shine on the sensitive points near the Rotator cuff joint in the small protrusion of the bone, below the tip of the shoulder. Shock wave will be performed once every five days for 4 consecutive weeks and in each session 3000 shocks with a frequency of 10 Hz.</i_keyword>
      <i_keyword>Control group: An exercise therapy program is offered for six weeks and three sessions each week (between 45 and 60 minutes) that From week three onward, they receive the same treatment as the experimental group for up to six weeks, While the shock wave device is off and is placed on the patient's shoulder at the same time.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Improve pain. Timepoint: Before starting the intervention- Six weeks after the intervention. Method of measurement: Visual Analogue Scale - Constant Murley Score.</prim_outcome>
      <prim_outcome>Improve range of motion. Timepoint: Before starting the intervention- Six weeks after the intervention. Method of measurement: Shoulder Pain And Disability Index.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-09-14</approval_date>
        <contact_name>Ethics Committee of Tabriz Universityy of Medical Sciences</contact_name>
        <contact_address>Ashpaz bashi Restaurant, front of Tareh Bar Square, Sheikh Shaltout Blvd urmia West Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
